Hannah E Bergom

6PUBLICATIONS
72CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|Sep 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases.

Megan L Ludwig, David Moline, Alec Horrmann

|Feb 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.

Zoi E Sychev, Abderrahman Day, Hannah E Bergom

|Jul 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate Cancer.

Alex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye

|May 01, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

Justin Hwang, Xiaolei Shi, Andrew Elliott

Pageof 1